Literature DB >> 17646586

A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database.

Adrian F Hernandez1, Joshua D Grab, James S Gammie, Sean M O'Brien, Bradley G Hammill, Joseph G Rogers, Margarita T Camacho, Mercedes K Dullum, T Bruce Ferguson, Eric D Peterson.   

Abstract

BACKGROUND: Previous studies showed 75% mortality before hospital discharge in patients with a ventricular assist device (VAD) placed for post-cardiac surgery shock. We examined a large national clinical database to assess trends in the incidence of post-cardiac surgery shock requiring VAD implantation, survival rates, and risk factors for mortality. METHODS AND
RESULTS: We identified patients undergoing a VAD procedure after cardiac surgery at US hospitals participating in the Society of Thoracic Surgeons' National Cardiac Database during the years 1995 to 2004. Baseline characteristics and operative outcomes were analyzed in 2.5-year increments. Logistic regression modeling was performed to provide risk-adjusted operative mortality and morbidity odds ratios. A total of 5735 patients had a VAD placed during the 10-year period (0.3% cardiac surgeries). Overall survival rate to discharge after VAD placement was 54.1%. With the earliest period (January 1995 through June 1997) used as reference, the mortality odds ratio declined to 0.72 (July 1997 through December 1999) and eventually to 0.41 (July 2002 through December 2004; P<0.0001). The combined mortality/morbidity odds ratio also declined, to 0.84 and 0.48 over identical periods (P<0.0001). Preoperative characteristics associated with increased mortality were urgency of procedure, reoperation, renal failure, myocardial infarction, aortic stenosis, female sex, race, peripheral vascular disease, New York Heart Association class IV, cardiogenic shock, left main coronary stenosis, and valve procedure (c index=0.755).
CONCLUSIONS: After adjustment for clinical characteristics of patients requiring mechanical circulatory support, rates of survival to hospital discharge have improved dramatically. Insertion of a VAD for post-cardiac surgery shock is an important therapeutic intervention that can salvage most of these patients.

Entities:  

Mesh:

Year:  2007        PMID: 17646586     DOI: 10.1161/CIRCULATIONAHA.106.666289

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  24 in total

Review 1.  Ventricular assist device therapy in post-cardiotomy cardiogenic shock: historical outcomes and current trends.

Authors:  Abdul Nasir; Pramod Bonde; Alastair N J Graham
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-07

2.  Should women receive left ventricular assist device support?: findings from INTERMACS.

Authors:  Eileen M Hsich; David C Naftel; Susan L Myers; Eiran Z Gorodeski; Kathleen L Grady; Darlene Schmuhl; Karen L Ulisney; James B Young
Journal:  Circ Heart Fail       Date:  2012-01-18       Impact factor: 8.790

3.  Clinical Characteristics and Outcomes of Patients With Myocardial Infarction and Cardiogenic Shock Undergoing Coronary Artery Bypass Surgery: Data From The Society of Thoracic Surgeons National Database.

Authors:  Deepak Acharya; Brian C Gulack; Renzo Y Loyaga-Rendon; James E Davies; Xia He; J Matthew Brennan; Vinod H Thourani; Matthew L Williams
Journal:  Ann Thorac Surg       Date:  2015-12-22       Impact factor: 4.330

Review 4.  Contemporary mechanical circulatory support therapy for postcardiotomy shock.

Authors:  Shinichi Fukuhara; Koji Takeda; Arthur Reshad Garan; Paul Kurlansky; Jonathan Hastie; Yoshifumi Naka; Hiroo Takayama
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-02-13

Review 5.  INTERMACS and MedaMACS: how will they guide future therapy?

Authors:  Garrick C Stewart; Lynne W Stevenson
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

6.  Short- and long-term survival of patients transferred to a tertiary care center on temporary extracorporeal circulatory support.

Authors:  Jonathan W Haft; Francis D Pagani; Matthew A Romano; Christina L Leventhal; D Bradley Dyke; Jennifer C Matthews
Journal:  Ann Thorac Surg       Date:  2009-09       Impact factor: 4.330

Review 7.  Mechanical support in acute and chronic heart failure.

Authors:  Andreas Brieke; Joseph Cleveland; JoAnn Lindenfeld
Journal:  Curr Cardiol Rep       Date:  2008-05       Impact factor: 2.931

8.  Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries.

Authors:  Adrian F Hernandez; Alisa M Shea; Carmelo A Milano; Joseph G Rogers; Bradley G Hammill; Christopher M O'Connor; Kevin A Schulman; Eric D Peterson; Lesley H Curtis
Journal:  JAMA       Date:  2008-11-26       Impact factor: 56.272

9.  The Thoratec CentriMag for pediatric right ventricular failure.

Authors:  Ashley B Hodge; Catherine J Yeager; Thomas J Preston; Andrew J Savage; Ryan J Butts; Minoo N Kavarana
Journal:  J Extra Corpor Technol       Date:  2013-06

10.  Short-term ventricular assist device in post-cardiotomy cardiogenic shock: factors influencing survival.

Authors:  Prashant N Mohite; Anton Sabashnikov; Nikhil P Patil; Diana García Sáez; Bartlomiej Zych; Aron F Popov; Alexander Weymann; Thorsten Wahlers; Nandor Marczin; Fabio DeRobertis; Toufan Bahrami; Mohamed Amrani; André R Simon
Journal:  J Artif Organs       Date:  2014-06-01       Impact factor: 1.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.